A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative content and banned associated hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.
After minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Item Details and Pricing
Within these groups, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious medical dangers”.
